John C Byrd

John C Byrd

UNVERIFIED PROFILE

Are you John C Byrd?   Register this Author

Register author
John C Byrd

John C Byrd

Publications by authors named "John C Byrd"

Are you John C Byrd?   Register this Author

100Publications

2410Reads

23Profile Views

Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia.

Support Care Cancer 2019 Jul 22. Epub 2019 Jul 22.

Department of Psychology, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04991-yDOI Listing
July 2019

A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2019 Jul 27:1-9. Epub 2019 Jul 27.

c Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1643463DOI Listing
July 2019

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.

Br J Clin Pharmacol 2019 May 27;85(5):924-934. Epub 2019 Feb 27.

Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475687PMC
May 2019

Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.

J Immunol 2019 May 25;202(9):2806-2816. Epub 2019 Mar 25.

Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478536PMC
May 2019

Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.

Br J Haematol 2019 Apr 20;185(2):363-366. Epub 2018 Jul 20.

Division of Hematology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15508DOI Listing
April 2019

Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib.

Leuk Lymphoma 2019 Apr 2;60(4):1000-1005. Epub 2018 Oct 2.

f Department of Medicine , University of California San Diego, Moores Cancer Center , San Diego , CA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1512710DOI Listing
April 2019

Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL.

Cancer Discov 2019 Mar;9(3):320-322

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-0029DOI Listing
March 2019

Targeting CD20 takes the backseat in CLL.

Authors:
John C Byrd

Blood 2019 Mar;133(10):1003-1004

The Ohio State University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2019-01-892695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405332PMC
March 2019

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance).

Leuk Lymphoma 2019 Mar 27:1-4. Epub 2019 Mar 27.

c Division of Hematology , The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1594218DOI Listing
March 2019

PLK1: a promising and previously unexplored target in double-hit lymphoma.

J Clin Invest 2018 12 5;128(12):5206-5208. Epub 2018 Nov 5.

Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center, and.

View Article

Download full-text PDF

Source
https://www.jci.org/articles/view/124919
Publisher Site
http://dx.doi.org/10.1172/JCI124919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264726PMC
December 2018

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

N Engl J Med 2018 12 1;379(26):2517-2528. Epub 2018 Dec 1.

From Ohio State University Comprehensive Cancer Center, Columbus (J.A.W., A.S.R., N.A.H., W.Z., K.A.R., G.L., J.S.B., H.G.O., J.C.B.); the Alliance Statistics and Data Center (A.S.R., A.M.B., B.M.-E., B.F., S.J.M.), Mayo Clinic (W.D., S.A.P., M.L.), Rochester, MN; Washington University School of Medicine, St. Louis (N.L.B.); Duke Cancer Institute, Duke University Medical Center, Durham (D.M.B., H.E.), and First Health of the Carolinas Cancer Center, Pinehurst (C.K.) - both in North Carolina; the University of Rochester Medical Center, Rochester, NY (P.M.B.); Stanford University School of Medicine, Stanford (S.C.), and the City of Hope Comprehensive Cancer Center, Duarte (A.H.) - both in California; Dana-Farber Partners CancerCare (J.R.B., R.M.S.) and the Massachusetts General Hospital Cancer Center (J.S.A.) - both in Boston; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN (S.N.); University of Chicago Comprehensive Cancer Center (R.A.L.) and Loyola University Chicago (S.E.S.) - both in Chicago; the University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); and the Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (R.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325637PMC
December 2018

Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation.

Biochemistry 2018 07 14;57(26):3564-3575. Epub 2018 Jun 14.

Department of Molecular, Cellular, and Developmental Biology , Yale University , New Haven , Connecticut 06511 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.biochem.8b00391DOI Listing
July 2018

HSP90 inhibition without heat shock response.

Authors:
John C Byrd

Blood 2018 07;132(3):241-242

The Ohio State University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-05-850271DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053952PMC
July 2018

Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.

Leuk Lymphoma 2018 06 18;59(6):1461-1465. Epub 2017 Sep 18.

a Department of Internal Medicine, Division of Hematology , The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1376742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029688PMC
June 2018

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.

J Clin Oncol 2017 Sep 17;35(26):3010-3020. Epub 2017 Jul 17.

Cameron J. Turtle, Kevin A. Hay, Laïla-Aïcha Hanafi, Shelly Heimfeld, Stanley R. Riddell, and David G. Maloney, Fred Hutchinson Cancer Research Center; Cameron J. Turtle, Sindhu Cherian, Xueyan Chen, Brent Wood, Stanley R. Riddell, and David G. Maloney, University of Washington; Daniel Li, Juno Therapeutics, Seattle, WA; and Arletta Lozanski and John C. Byrd, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590803PMC
September 2017

Spotlight on Ibrutinib in PCNSL: Adding Another Feather to Its Cap.

Cancer Discov 2017 09;7(9):940-942

The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0714DOI Listing
September 2017

The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.

Cancer Med 2017 Apr 15;6(4):778-787. Epub 2017 Mar 15.

Division of Hematology, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387133PMC
April 2017